image: MRI images tracking the progression of a recurrent glioblastoma in a patient after undergoing surgical removal of the tumor. This material relates to a paper that appeared in the August 14, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by E.A. Chiocca at Brigham and Women's Hospital in Boston, MA; and colleagues was titled, "Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial." view more
Credit: E.A. Chiocca <i>et al., Science Translational Medicine</i> (2019)